TPM3 and colorectal neoplasm: We originally reported the identification of a chromosomal rearrangement involving NTRK1 (encoding the TRKA protein) and the TPM3 gene in the KM12 colorectal tumor cell line and showed for the first time that the resulting TPM3-TRKA fusion protein is an oncogenic driver sensitive to TRKA inhibitors.